GSK neck and neck with Pfizer in the race to get first RSV jab to marketProactive Investors • 03/02/23
Pfizer Receives Positive FDA Advisory Committee Votes Supporting Potential Approval for Vaccine Candidate to Help Combat RSV in Older AdultsBusiness Wire • 02/28/23
FDA advisors recommend Pfizer RSV vaccine for older adults, despite possible Guillain-Barre risksCNBC • 02/28/23
Seagen stock rises as Pfizer reportedly in talks to acquire Seattle-area biotech giantGeekWire • 02/27/23
'Here We Go Again': Seagen Soars As Pfizer Reportedly Mulls A TakeoverInvestors Business Daily • 02/27/23
Seagen's stock surges 15% after a report that Pfizer is in talks to buy the cancer-focused biotechBusiness Insider • 02/27/23
Seagen's stock soars on reported Pfizer buyout interest; Union Pacific shares rally after CEO ousterMarket Watch • 02/27/23